The hunt for drugs to modify Alzheimer's disease - PubMed (original) (raw)
The hunt for drugs to modify Alzheimer's disease
James Butcher. Lancet Neurol. 2007 Dec.
No abstract available
Similar articles
- Alzheimer's disease: clinical trials and drug development.
Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Mangialasche F, et al. Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8. Lancet Neurol. 2010. PMID: 20610346 Review. - The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Yaffe K, Tocco M, Petersen RC, Sigler C, Burns LC, Cornelius C, Khachaturian AS, Irizarry MC, Carrillo MC. Yaffe K, et al. Alzheimers Dement. 2012 May;8(3):237-42. doi: 10.1016/j.jalz.2011.12.005. Alzheimers Dement. 2012. PMID: 22546356 - Preclinical Alzheimer's disease therapeutics.
Rafii MS. Rafii MS. J Alzheimers Dis. 2014;42 Suppl 4:S545-9. doi: 10.3233/JAD-141482. J Alzheimers Dis. 2014. PMID: 25079804 Review. - Atypical antipsychotic drugs and Alzheimer's disease.
Hussain HM, Hotopf M, Oyebode F. Hussain HM, et al. N Engl J Med. 2007 Jan 25;356(4):416; author reply 417-8. doi: 10.1056/NEJMc063094. N Engl J Med. 2007. PMID: 17251541 Retracted. No abstract available. - Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
Raskind MA. Raskind MA. J Clin Psychiatry. 1998;59 Suppl 9:28-32. J Clin Psychiatry. 1998. PMID: 9720484 Review.
Cited by
- Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain.
Kim J, Ahn SW, Deans K, Thompson D, Ferland B, Divakar P, Dominas C, Jonas O. Kim J, et al. Front Bioeng Biotechnol. 2022 Mar 18;10:855755. doi: 10.3389/fbioe.2022.855755. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35372313 Free PMC article. - Why so few drugs for Alzheimer's disease? Are methods failing drugs?
Becker RE, Greig NH. Becker RE, et al. Curr Alzheimer Res. 2010 Nov;7(7):642-51. doi: 10.2174/156720510793499075. Curr Alzheimer Res. 2010. PMID: 20704560 Free PMC article. Review. - Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?
Becker RE, Greig NH. Becker RE, et al. J Clin Psychopharmacol. 2009 Feb;29(1):56-64. doi: 10.1097/JCP.0b013e318192e2fa. J Clin Psychopharmacol. 2009. PMID: 19142109 Free PMC article. - Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?
Becker RE, Greig NH, Giacobini E. Becker RE, et al. J Alzheimers Dis. 2008 Oct;15(2):303-25. doi: 10.3233/jad-2008-15213. J Alzheimers Dis. 2008. PMID: 18953116 Free PMC article. Review. - Alzheimer's disease drug development: old problems require new priorities.
Becker RE, Greig NH. Becker RE, et al. CNS Neurol Disord Drug Targets. 2008 Dec;7(6):499-511. doi: 10.2174/187152708787122950. CNS Neurol Disord Drug Targets. 2008. PMID: 19128207 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical